Role of PET/CT in Peritoneal Deposits Assessment

Sponsor
Aya Khaled Mahmoud (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06137417
Collaborator
(none)
50
26.4

Study Details

Study Description

Brief Summary

• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits

Condition or Disease Intervention/Treatment Phase
  • Device: PET/CT

Detailed Description

Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits. we will find its diagnostic role.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Role of PET/CT in Peritoneal Deposits Assessment
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Jan 1, 2026
Anticipated Study Completion Date :
Mar 15, 2026

Outcome Measures

Primary Outcome Measures

  1. role of pet/ct in peritoneal deposits assessment [2 years]

    Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • • Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.
Exclusion Criteria:
  • • Patients unable to sit calm without movement during imaging.

  • Severely ill patients.

  • Patients unable to sleep in a fixed position for 20 minutes.

  • Pregnancy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Aya Khaled Mahmoud

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Aya Khaled Mahmoud, assistant lecturer, Assiut University
ClinicalTrials.gov Identifier:
NCT06137417
Other Study ID Numbers:
  • PET CT peritoneal deposits
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023